Home Cart Sign in  
Chemical Structure| 40957-83-3 Chemical Structure| 40957-83-3

Structure of Glycitein
CAS No.: 40957-83-3

Chemical Structure| 40957-83-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Glycitein, a soybean isoflavonoid with anti-oxidation, can induce the expression of antioxidant genes like antioxidant response element (ARE). It is also used in the study of apoptosis when combination with other isoflavonoids such as genistein and daidzein.

Synonyms: Glycetein

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Glycitein

CAS No. :40957-83-3
Formula : C16H12O5
M.W : 284.26
SMILES Code : O=C1C(C2=CC=C(O)C=C2)=COC3=C1C=C(OC)C(O)=C3
Synonyms :
Glycetein
MDL No. :MFCD00016679
InChI Key :DXYUAIFZCFRPTH-UHFFFAOYSA-N
Pubchem ID :5317750

Safety of Glycitein

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01232751 Postmenopause Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Gelderland, Netherlands, 6703 HD Less <<
NCT03008785 Bloodpressure Not Applicable Completed - Brazil ... More >> Guilherme Morais Puga Uberlandia, Minas Gerais, Brazil, 38400-678 Less <<
NCT01048606 Overweight Phase 4 Completed - Canada, Quebec ... More >> Centre de recherche sur le vieillissement du CSSS-IUGS Sherbrooke, Quebec, Canada, J1H 4C4 Less <<
NCT01463436 Cardiovascular Disease ... More >> Osteoporosis Less << Phase 3 Completed - Indonesia ... More >> Trisakti University Jakarta, DKI Jakarta, Indonesia Less <<
NCT03167827 Pelvic Floor Phase 4 Completed - -
NCT01048606 - Completed - -
NCT00491595 Drug Toxicity Phase 1 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.52mL

0.70mL

0.35mL

17.59mL

3.52mL

1.76mL

35.18mL

7.04mL

3.52mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories